Desferrioxamine MesilateThird Party Manufacturing in India

Desferrioxamine Mesilate works by binding trivalent iron ions to form a stable, non-toxic complex called ferrioxamine. It inhibits free iron accumulation and cellular toxicity to help the body excrete excess iron through renal and biliary routes. Unlike general heavy-metal chelators, it possesses a remarkably high specific affinity for iron over essential divalent cations. Sourcing via our established partner facilities ensures optimal purity under CAS 138-14-7. It is highly effective and well-tolerated.

Therapeutic Uses

• Chronic Iron Overload: Primary maintenance therapy for transfusion-dependent thalassemia and congenital anemias.
• Acute Iron Poisoning: Administered as an emergency antidote for accidental acute iron ingestion emergencies.
• Aluminum Overload: Applied to reduce high systemic aluminum levels in patients undergoing long-term dialysis.

Why Manufacturers Choose Desferrioxamine Mesilate

This iron-chelator is highly demanded due to its life-saving indications and consistent public health procurement cycles. Establishing Desferrioxamine Mesilate third party manufacturing in India provides distributors with stable entry into specialized hematology markets. Sourcing through our select partner facilities offers full adherence to WHO-GMP regulations. The product provides exceptional clarity upon reconstitution and complies with strict particulate matter standards.